ADC THERAPEUTICS SA (ADCT) Stock Cash Flow
NYSE:ADCT - New York Stock Exchange, Inc. - CH0499880968 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -212.82M | -240.05M | -155.80M | -230.03M | -246.29M | |||
| Depreciation Amortization | -76.00K | 1.19M | 2.33M | 2.63M | 2.15M | |||
| Income Taxes - Deferred | 45.75M | 37.10M | -710.00K | -26.05M | N/A | |||
| Change In Working Capital | 13.43M | 45.88M | -65.90M | -26.39M | 11.57M | |||
| Interest Paid | N/A | N/A | 21.37M | 5.49M | 1.56M | |||
| Taxes Paid | N/A | N/A | 13.47M | 670.00K | 30.00K | |||
| Other non cash items | 18.67M | 37.20M | 83.29M | 46.46M | 63.85M | |||
| OPERATING CASH FLOW | -135.06M | -118.69M | -136.79M | -233.38M | -168.73M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.10M | -3.22M | -2.30M | -6.38M | -2.81M | |||
| Other Investing Activity | N/A | N/A | -210.00K | -300.00K | -20.00K | |||
| INVESTING CASH FLOW | -1.30M | -3.22M | -2.51M | -6.67M | -2.83M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 73.10M | -6.50M | 266.62M | 61.75M | |||
| Stock Issued/Repurchased | N/A | 773.00K | 5.91M | 780.00K | 433.21M | |||
| FINANCING CASH FLOW | 99.81M | 73.88M | -590.00K | 267.39M | 494.97M | |||
| Exchange Rate Effect | 412.00K | 184.00K | -210.00K | 10.00K | 240.00K | |||
| CHANGE IN CASH | -36.14M | -47.84M | -140.10M | 27.35M | 323.65M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -135.06M | -118.69M | -136.79M | -233.38M | -168.73M | |||
| Capital Expenditure | -1.10M | -3.22M | -2.30M | -6.38M | -2.81M | |||
| FREE CASH FLOW | -136.16M | -121.90M | -139.09M | -239.76M | -171.54M | |||
All data in USD